Position statement on the diagnosis and management of acromegaly: The French National Diagnosis and Treatment Protocol (NDTP)
Thierry Brue(Inserm), F. Albarel, Frédéric Castinetti(Inserm), Jérôme Bertherat(Centre National de la Recherche Scientifique), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), Olivier Chabre(Hôpital Albert Michallon), Anne Barlier(Inserm), D. Drui(Centre Hospitalier Universitaire de Nantes), Rachel Reynaud(Hôpital de la Timone), Philippe Chanson(Bicêtre Hospital), Christine Cortet, Nicolas Chevalier(Inserm), Gérald Raverot(Université Claude Bernard Lyon 1), Marie‐Christine Vantyghem(Inserm), Philippe Touraine(Sorbonne Université), Chiara Villa(Centre National de la Recherche Scientifique), Françoise Borson‐Chazot(Hospices Civils de Lyon), Frédéric Lioté(Inserm), Abdoulaye Barry(Hôpital de la Conception), Isabelle Pellegrini(Hôpital de la Conception), Laure Cazabat(Hôpital Foch), H. Rahabi(Hôpital de la Conception), Peter Kamenický(Inserm), R. Coutant(Centre Hospitalier Universitaire de Tours), Igor Tauveron(Inserm), Sophie Christin-Maître(Inserm), Bruno Vergès(Inserm), C Lançon, Sylvie Salenave(Université Paris-Sud)
Cited by 17
Related Papers
Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
|Clinical Endocrinology|2006|830
SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma
|Cancer Cell|2013|772
Guidelines for Acromegaly Management: An Update
|The Journal of Clinical Endocrinology & Metabolism|2009|763
Human Health and Ocean Pollution
|Annals of Global Health|2020|751
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
|Cancer Cell|2016|665